Connection
Natalie Serkova to Infusions, Intravenous
This is a "connection" page, showing publications Natalie Serkova has written about Infusions, Intravenous.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.021 |
|
|
|
-
Spratlin JL, Cohen RB, Eadens M, Gore L, Camidge DR, Diab S, Leong S, O'Bryant C, Chow LQ, Serkova NJ, Meropol NJ, Lewis NL, Chiorean EG, Fox F, Youssoufian H, Rowinsky EK, Eckhardt SG. Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2. J Clin Oncol. 2010 Feb 10; 28(5):780-7.
Score: 0.021